Multidisciplinary management of brain tumours

The course is primarily aimed at specialists and trainees in the field of clinical/radiation oncology interested in extending their knowledge of the multidisciplinary management of central nervous system tumours. Other specialists with interest in brain tumours who wish to have an update on brain tumour treatment approaches with a particular focus on radiotherapy will also be most welcome.

Course directors 

  • Sarah Jefferies, Clinical Oncologist, Addenbrooke’s Hospital - Oncology Centre, Cambridge (UK) 
  • Gianfranco Pesce, Clinical Oncologist, Radiation Oncology, Oncology Institute of Southern Switzerland, Ospedale S.Giovanni, Bellinzona (CH)


  • Ranjeev Bhangoo, Neurosurgeon, Kings College Hospital, London (UK) 
  • Michael Brada, Professor of Radiation Oncology, University of Liverpool (UK)
  • Anthony Chalmers, Clinical Oncologist, Institute of Cancer Sciences, University of Glasgow, The Beatson West of Scotland Cancer Centre, Glasgow (UK) 
  • Tilak Das, Consultant Neuroradiologist, Addenbrooke’s Hospital - Oncology Centre, Cambridge (UK) 
  • Patrick Roth, Medical Neurologist, University Hospital Zürich, Zurich (CH)  
  • Kathreena M Kurian, Neuropathologist, Neuropathology, Southmead Hospital, Southmead Road, Bristol (UK)


The course aims to review the present state-of-the-art of neuro-oncology from its biological understanding to the implementation of high-tech radiotherapy approaches, modern biologically driven therapy and care. It will not only cover the commonest of brain tumours, but will also review the latest developments in the less common tumours in adults and children.

Learning outcomes

By the end of this course participants should be able to:

  • Understand the evolving concepts of brain tumour biology
  • Interpret more complex brain imaging for the purpose of therapy
  • Make judgements regarding multidisciplinary management of tumours including the role of systemic and targeted therapies in both common and rare brain tumours in adults and children
  • Understand the principles and practice of modern radiotherapy
  • Understand the design and challenges of brain tumour clinical trials.

Course content

Neuro-oncology is generally equated with the management of malignant gliomas, yet it is the speciality with perhaps the largest range of tumour types from curable to barely treatable. It has been at the forefront of technical developments in radiotherapy with early implementation of the latest imaging and high precision localised radiotherapy, including stereotactic radiotherapy and proton therapy. Neurosurgery has also developed in leaps and bounds so that previously inaccessible locations can now be safely reached. Local treatment relies on accurate imaging and this is the cornerstone of neuro-oncology practice.

Alongside local treatment approaches, systemic treatment has become mainstay of management of many tumours in adults and children and targeted personalised therapy approaches are becoming a reality. The need for developing and testing new therapies in this challenging clinical setting requires the involvement of neuro-oncology specialists in clinical trials and the issues specific to brain tumour trial design are of importance to the future of the speciality.

Anyone involved in neuro-oncology is aware of the challenges in treating the brain and the short and long term consequences for the patient and their carers, and that attention to care is an integral part of neuro-oncology.


Before commencing this course you should have some:

  • Experience of brain tumour management
  • Understanding of conventional brain radiotherapy issues.

Teaching methods

  • 12-15 hours of lectures
  • 3-5 hours of discussions

Interactive and didactic lectures will be complemented by practical radiotherapy planning practice.

Methods assessment

  • MCQ
  • Q&A
  • Evaluation form.




The scientific programme is available here

Further reading / web resources

To be provided if available.


Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.


ESTRO members can order products at substantially reduced prices. Please note that in order to benefit from the member price, you must renew your membership for 2021 before registering to the course.To benefit from these member rates, please visit the membership page to become a member or renew your membership BEFORE proceeding with your order.



Standard Rate

Desk Rate

ESTRO members working in countries with a less competitive economic background*/ In-training members**

 350 EUR

 600 EUR


 400 EUR 

 600 EUR

Non Members

 500 EUR

 600 EUR

*  All specialties: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia,, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Portugal, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, Spain, Turkey, Ukraine

RTTs and physicists only: Cyprus  

RTTs only: Italy 

To apply for the above rate, please contact  before Wednesday 17th November 2021. Thereafter, the desk rate will be applied.

** Members with specialty Radiation Therapist (RTT) may register at the In Training fee

The standard rate is applied until Wednesday 17th November 2021

Desk rates are applied after Wednesday 17th November 2021


Advance registration & payment are required.              

Registration will close on the date published on the front page of the course.


A registration to the online workshop may be cancelled without any fees before pre-online course material is sent out. Pre-online course material is sent out a few days before the first workshop lesson. After the pre-online course material is sent out, no refund of the  registration fee is possible.

Fee for ESTRO members working in countries with a less competitive economic background:

ESTRO members working in countries with a less competitive economic background can benefit from the above fees if three conditions are met:

  1. Only ESTRO members for 2021 are eligible (please make sure your 2021 membership is in order before you apply for the reduced fees
  2. Sponsored candidates are not entitled to these fees (the invoicing address has to be the one of the participant)  
  3. Your application is submitted before Wednesday 17th November 2021

Early deadline 17/11/2021